UNSPSC 41141613: Creatine kinase

In this classification, this entry connotes a Creatine kinase enzyme that is used in clinical chemistry testing.

UNSPSC 41141613 Creatine kinase is a Commodity code that names a single clinical laboratory reagent, but the recent state and local opportunities tagged under it reveal a much broader scope: laboratory diagnostic consumables including nextgen sequencing kits for pathogen detection, culture media for foodborne and waterborne pathogen testing, solid phase extraction disks for drinking water analysis, gas chromatography columns and chemical standards for EPA-mandated testing, mycobacterial identification reagents, and certified spiking solutions for forensic analysis. Texas Health and Human Services Commission (HHSC) and the Department of State Health Services (DSHS) dominate the recent activity, issuing at least five IFBs since late February 2026 for consumable laboratory reagents and supplies supporting public health surveillance, outbreak investigation, and environmental compliance testing. The Mississippi State Department of Health (MSDH) has posted sole-source procurements for whole genome sequencing reagent bundles from Clear Labs and Illumina, while the State of California, the City of Philadelphia, and the University of Texas Health Science Center at San Antonio have also solicited under this code, suggesting that laboratory consumable procurement spans state health departments, municipal public health labs, university medical centers, and specialized surveillance programs.

The geographic spread centers on Texas, with secondary activity in Mississippi and California; the most recent representative opportunities include HHSC IFB HHS0017272 for Illumina Viral Surveillance Panel kits and Respiratory Pathogen ID/AMR Enrichment Kit Sets (due May 19, 2026, with historical spend of $35,050 to $90,000), HHSC IFB HHS0017132 for R&F brand culture media for Escherichia coli O157:H7 and Listeria detection (due June 2, 2026, with FY2026 spend of $187,340), MSDH sole-source procurement for Clear Labs reagent bundles totaling $226,072 (objection deadline May 14, 2026), and MSDH sole-source procurement for Illumina kits totaling $393,667.98 (objection deadline May 14, 2026). The City of Philadelphia issued a micro purchase RFQ for Clean Thru Extraction Columns due May 30, 2026 with a $43,000 ceiling, and the University of Texas Health Science Center at San Antonio released RFP 745-26-P19 for a comprehensive biotech research and clinical diagnostics catalog with approximately 8,768 line items ordered in the prior year (due June 4, 2026). Most HHSC procurements use firm fixed pricing on IFBs with federal and state affirmation requirements; sole-source activity in Mississippi reflects lock-in to existing sequencer platforms (Clear Dx and Illumina MiSeq/NextSeq/iSeq), and volume is episodic rather than standing, tied to surveillance cycles, outbreak response, and lab throughput.